Table 1.
Baseline demographic and clinical parameters of the study population
| Standard | Low | Total | |
|---|---|---|---|
| N | 20 | 23 | 43 |
| Age (years) | 67 (55–76) | 68 (59–77) | 68 (59–77) |
| Gender | |||
| Male | 13 (65) | 16 (70) | 29 (67) |
| Female | 7 (35) | 7 (30) | 14 (33) |
| Ethnicity | |||
| Caucasian | 14 (70) | 13 (56) | 27 (63) |
| Asian | 1 (5) | 5 (22) | 6 (14) |
| African | 5 (25) | 5 (22) | 10 (23) |
| Time on Dialysis (months) | 60 (37–99) | 56 (37–118) | 58 (37–114) |
| MOCA | 21.9 ± 4.6 | 20.7 ± 6.2 | 21.2 ± 5.5 |
| HADS Depression | 6.5 ± 3.5 | 4.8 ± 2.4 | 5.6 ± 3.0 |
| HADS Anxiety | 3.0 (1.0–8.0) | 3.0 (1.0–4.0) | 3.0 (1.0–5.5) |
| AQOL | 48.1 ± 9.6 | 45.6 ± 8.2 | 47.7 ± 8.8 |
| PreHD SBP (mmHg) | 147.2 ± 24.1 | 140.0 ± 20.4 | 143.3 ± 22.2 |
| preHD DBP (mmHg) | 72.9 ± 13.4 | 65.9 ± 10.3 | 69.0 ± 12.2 |
| Post HD SBP (mmHg) | 130.9 ± 21.0 | 132.6 ± 14.3 | 131.9 ± 17.4 |
| Post HD DBP (mmHg) | 62.0 ± 12.5 | 63.9 ± 10.5 | 63.0 ± 11.3 |
| Kt/V | 1.33 ± 0.16 | 1.36 ± 0.26 | 1.34 ± 0.22 |
| Hb (g/dL) | 11.5 ± 0.94 | 11.0 ± 1.17 | 11.2 ± 1.09 |
| Alb (g/L) | 32.8 ± 3.9 | 31.4 ± 4.2 | 32.1 ± 4.1 |
| C.Ca (mmol/L) | 2.40 ± 0.15 | 2.40 ± 0.12 | 2.40 ± 0.13 |
| Phosphate (mmol/L) | 1.60 (1.41–2.04) | 1.30 (1.18–1.70) | 1.50 (1.19–1.84) |
| PTH (pmol/L) | 48.2 ± 28.0 | 45.5 ± 23.9 | 46.7 ± 25.6 |
Data presented as either Mean ± SD; Median (IQR); N (%)